This is the authors' abstract. We don't add key points for this paper.
A 15-year-old male was referred to us with pruritic eruptions on the lower legs where an IPCD had been applied, and on the abdomen where adhesive tape had been applied. The patient had been diagnosed with refractory chronic hepatitis due to pancreas divisum, and from allergic contact dermatitis caused by adhesive tape used for medical purposes. Seven days previously, the patient had undergone pancreatoduodenectomy, and the eruptions on the abdomen had appeared 5 days before his referral. The eruptions on the lower legs were first seen 2 days earlier. Physical examination revealed pruritic erythematous figures on the lower legs (Figure 1) and pruritic erythematous linear macules and vesicles on the abdomen. The shape and size of the eczema on the lower legs completely corresponded to the figures printed on the device. In addition, linear eczema was present on the areas where adhesive tape had been applied. Patch testing with Patch Test Panel(s) (Sato Pharmaceutical, Tokyo, Japan) was performed using the Japanese baseline series and showed a + positive reaction to colophonium at day (D) 2 and D4. The manufacturer of the device disclosed that the illustration printed on the IPCD contained hydrogenated rosin ester, but had no further information on the other chemicals used in the illustration. Patch testing with the other ingredients was not performed because the patient's parents did not consent to further examination. Topical application of difluprednate 0.05% ointment to the lesions led to their resolution.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Oiso et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: